Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
102.62
0.00 (0.00%)
At close: Aug 11, 2026, 4:00 PM EDT
104.13
+1.51 (1.47%)
After-hours: Aug 11, 2026, 7:58 PM EDT
Halozyme Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $93 → $105 | Buy | Reiterates | $93 → $105 | +2.32% | Aug 7, 2026 |
| Leerink Partners | Leerink Partners | Buy Upgrades $83 → $110 | Buy | Upgrades | $83 → $110 | +7.19% | Aug 7, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $92 → $93 | Buy | Maintains | $92 → $93 | -9.37% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $95 → $115 | Buy | Reiterates | $95 → $115 | +12.06% | Aug 7, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $75 → $95 | Hold | Reiterates | $75 → $95 | -7.43% | Aug 7, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $96 → $105 | Buy | Reiterates | $96 → $105 | +2.32% | Aug 7, 2026 |
| Goldman Sachs | Goldman Sachs | Sell Maintains $57 | Sell | Maintains | $57 | -44.46% | Jun 15, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Hold Maintains $70 | Hold | Maintains | $70 | -31.79% | May 20, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.